Form 4: Cyanotech Director Michael Davis Increases Stake in Company

Sentiment:

SEC Form 4 Filing


Director Michael Davis has increased his stake in Cyanotech through recent purchases of common stock.

Summary

  • Michael Davis, a director and 10% owner of Cyanotech Corporation, has reported changes in his beneficial ownership of the company's stock.
  • On July 10, 2024, Davis purchased 5,000 shares of Cyanotech common stock at a price of $0.39 per share.
  • On July 11, 2024, Davis purchased an additional 5,000 shares at $0.45 per share.
  • Following these transactions, Davis directly owns 12,119 shares and indirectly owns 1,076,736 shares through a revocable trust.
  • He also indirectly owns 31,250 shares through his spouse, 150,000 shares as co-trustee for the Nyracai Davis Irr. Trust and the Nettizanne J. Davis Irr. Trust, 58,000 shares as trustee for the Nettizanne Johnstone Davis GST Exempt Trust, and 58,789 shares as trustee for the Nyracai Johnstone Davis GST Exempt Trust.
  • The purchases were made pursuant to a pre-arranged 10b5-1(c) trading plan adopted on March 6, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The director's increased stake suggests confidence, but it's a relatively small transaction executed under a pre-existing plan.

Positives

  • A director increasing their stake in the company can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider buying is often monitored as an indicator of management's confidence in the company's prospects. It's a common practice for executives and directors to have pre-arranged trading plans (Rule 10b5-1) to avoid accusations of trading on inside information.

Stakeholder Impact

  • The increased stake by a director could positively influence shareholder sentiment.

Key Dates

DateDescription
03-06-2024Adoption date of the 10b5-1(c) plan
07/10/2024Purchase of 5,000 shares at $0.39
07/11/2024Purchase of 5,000 shares at $0.45
07/12/2024Date of signature on the Form 4 filing

Keywords

Cyanotech, insider trading, beneficial ownership, Form 4, Michael Davis, stock purchase, director, CYAN

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.